Trial intelligence / Profile preview

Propofol versus dexmedetomidine for ICU sedation in adult trauma patients

IRCT20190117042390N2Phase 4Completed

Sponsor
Rafsanjan University of Medical Sciences
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in Physical trauma, traumatic brain injury (TBI) and chest injury comparing Propofol arm with Dexmedetomidine arm (2 arms). Primary endpoints: Hemodynamic changes and Delirium. Started Mar 2023; status: completed.

02

Drugs

propofoldexmedetomidine
03

Conditions

Physical traumatraumatic brain injury (TBI)chest injury

Beyond the preview

Go deeper on IRCT20190117042390N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190117042390N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call